81 completed, 30 unknown, 14 not yet recruiting, 10 terminated. 153 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 153 | Completed 81, Unknown 30, Not yet recruiting 14, Terminated 10, Recruiting 9, Withdrawn 7, Active not recruiting 1, Suspended 1 |
Follow Stomach Diseases: new trials by email Literature Review of Stomach Diseases trials Research Report on Stomach Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric Cancer Zolbetuximab, Oxaliplatin, Folinic Acid - Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Phase 4 | Not yet recruiting | Astellas Pharma Global Development, Inc. | 50 | 2026-11-30 | 2026-09-21 |
| A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) Pembrolizumab, Cisplatin, 5-Fluorouracil - Neoplasm Malignant, Gastric Neoplasms | Phase 4 | Not yet recruiting | Merck Sharp & Dohme LLC | 150 | 2026-11-06 | 2026-09-03 |
| Vonoprazan High-Dose Dual VS Levofloxacin Concomitant Vonoprazan, Levofloxacin 500mg - Helicobacter Pylori Infection, Peptic Ulcer Disease | Phase 4 | Not yet recruiting | Damascus Hospital | 150 | 2026-11-01 | 2026-06-03 |
| PPI Dosing Per CYP2C19 Genotype CYP2C19 based dosing Proton Pump Inhibitors, Conventional proton pump inhibitor dose - Gastroesophageal Reflux Disease With Esophagitis | Phase 4 | Not yet recruiting | University of Florida | 200 | 2026-10-01 | 2026-09-28 |
| Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia After Radical Gastrectomy for Gastric Cancer Ferric Carboxymaltose (FCM), Iron Sucrose. - Gastric Cancer (GC), Iron Deficiency Anemia (IDA) | Phase 4 | Not yet recruiting | Zhaojian Niu,MD | 160 | 2026-08-01 | 2026-08-19 |
| A Phase IV Randomized Trial of Maxigesic® Versus Standard Analgesia After Radical Gastrectomy Acetaminophen (Newaminophen Premix), Maxigesic IV (acetaminophen/ibuprofen) - Stomach Neoplasms, Pain | Phase 4 | Not yet recruiting | Yonsei University | 160 | 2026-07-01 | 2026-07-07 |
| Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis Stillen Tab., Sto M Tab. - Gastritis, Acute Gastritis | Phase 4 | Not yet recruiting | Mather's Pharm. Co., Ltd. | 470 | 2026-06-01 | 2026-06-05 |
| A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma Iparomlimab and Tuvonralimab (QL1706) - Gastric Cancer (Diagnosis), Gastric Cancer (GC) | Phase 4 | Not yet recruiting | Huazhong University of Science and Technology | 55 | 2026-06-01 | 2026-03-30 |
| Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing Esomeprazole (Intravenous), Esomeprazole (Oral), Sucralfate Suspension - Early Gastric Cancer, Gastric Dysplasia | Phase 4 | Not yet recruiting | LanZhou University | 120 | 2026-04-20 | 2026-03-23 |
| Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication vonoprazan-based triple therapy (VAL regimen), Esomeprazole-based triple therapy (EAL regimen) - Helicobacter Pylori Infection, Dyspepsia | Phase 4 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 80 | 2026-04-15 | 2026-10-26 |
| RCT Comparing Reduced-port Robotic and Conventional Laparoscopic Subtotal Gastrectomy conventional laparoscopy gastrectomy group (Port > 3), reduced-port robotic group (Port ≤ 3) - Gastric Cancer | Phase 4 | Not yet recruiting | Yonsei University | 538 | 2026-04-01 | 2026-03-12 |
| Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment Bismuth, Esomeprazole, Tetracycline - Gastritis, Dyspepsia | Phase 4 | Recruiting | Yongquan Shi | 1248 | 2025-10-28 | 2025-12-02 |
| Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) CYTALUX™ (pafolacianine) - Gastrointestinal Cancer, Gastric Cancer | Phase 4 | Recruiting | Cedars-Sinai Medical Center | 15 | 2025-09-05 | 2025-09-15 |
| CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Eradication Arm 1: Dexlansoprazole + Levofloxacin-Based Triple Therapy, Arm 2: Lansoprazole + Levofloxacin-Based Triple Therapy, Arm 3: Vonoprazan + Levofloxacin-Based Triple Therapy - H. Pylori Gastrointestinal Disease, H.Pylori Infection | Phase 4 | Recruiting | Dow University of Health Sciences | 942 | 2025-05-01 | 2026-01-15 |
| Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial Vonoprazan, Tetracycline 500mg tid, Minocycline - Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer | Phase 4 | Recruiting | Yongquan Shi | 400 | 2025-04-01 | 2025-08-14 |
| Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2 PYTEST® 14C-Urea Capsule Breath Test (at Home), PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person) - H. Pylori Infection, Gastric Cancer | Phase 4 | Completed | University of Miami | 50 | 2024-11-06 | 2026-10-16 |
| Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection Vonoprazan, Esomeprazole - Ulcers, Gastric | Phase 4 | Not yet recruiting | Shicai Ye | 196 | 2024-08-01 | 2024-07-29 |
| Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy GLP-1 medication - Diabetes Mellitus, Type 2, Obesity | Phase 4 | Completed | The Cleveland Clinic | 69 | 2024-07-31 | 2025-12-05 |
| Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer Irinotecan Hydrochloride Liposome Injection - Gastric Cancer | Phase 4 | Not yet recruiting | First Affiliated Hospital Xi'an Jiaotong University | 44 | 2024-07-15 | 2024-07-12 |
| Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients Huaier granule, Oxaliplatin, Tegafur, Gimeracil and Oteracil Potassium - Gastric Cancer | Phase 4 | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 702 | 2024-07-01 | 2024-06-24 |
Showing 20 of 153. Sign in to see all of them.
Stomach Neoplasms (66) · Peptic Ulcer (36) · Gastritis (19) · Dyspepsia (15) · Stomach Ulcer (15) · Esophageal Neoplasms (12) · Gastroparesis (10) · Esophagitis, Peptic (9) · Pancreatic Neoplasms (8) · Duodenal Ulcer (7) · Gastroesophageal Reflux (7) · Neoplasms (7) · Peptic Ulcer Hemorrhage (5) · Carcinoma, Hepatocellular (4)
Digestive System Diseases (152) · Gastrointestinal Diseases (152) · Intestinal Diseases (73) · Neoplasms by Site (68) · Digestive System Neoplasms (67) · Duodenal Diseases (67) · Gastrointestinal Neoplasms (66) · Neoplasms (61) · Pathological Conditions, Signs and Symptoms (53) · Signs and Symptoms (33) · Gastroenteritis (31) · Peptic Ulcer (30) · Esophageal Diseases (24) · Pathologic Processes (21)
Esomeprazole (18) · Amoxicillin (16) · Bismuth (12) · Clarithromycin (12) · Omeprazole (11) · Lansoprazole (7) · Rabeprazole (7) · Oxaliplatin (6) · Famotidine (5) · Fluorouracil (5) · rebamipide (5) · 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (4) · Berberine (4) · Furazolidone (4) · Metronidazole (4)
Xijing Hospital of Digestive Diseases (11) · Yonsei University (5) · AstraZeneca (3) · Chinese University of Hong Kong (3) · Shanghai Jiao Tong University School of Medicine (3) · Asan Medical Center (2) · Daewoong Pharmaceutical Co. LTD. (2) · Damascus Hospital (2) · Eisai Co., Ltd. (2) · Far Eastern Memorial Hospital (2) · Jagiellonian University (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Kaohsiung Veterans General Hospital. (2) · Mayo Clinic (2) · National Taiwan University Hospital (2)
China (39) · United States (28) · South Korea (21) · Taiwan (8) · Japan (5) · Switzerland (5) · Denmark (4) · Netherlands (4) · France (3) · Greece (3) · Poland (3) · Spain (3) · United Kingdom (3) · Belgium (2) · Canada (2)
Yongquan Shi, Ph. D (4) · Hong Lu, M.D. (2) · Adolfo Parra-Blanco, MD (1) · Allan Okrainec (1) · An Lambaerts (1) · Anders Perner, MD, PhD (1) · Anton Bermont, MD (1) · Antone R Opekun, PA-C (1) · Arto Kokkola, MD (1) · Austin G Acheson, MD FRCS (1) · Barrie D Keeler, FRCS (1) · Ben D Albert, MD (1) · Bon-Nyeo Koo, MD, Ph.D (1) · Byeong Ug Kim (1)
PMID 10022643, PMID 10343249, PMID 11156645, PMID 11822956, PMID 11857360, PMID 12170403, PMID 1305308, PMID 1479177, PMID 15044883, PMID 15645403, PMID 15738894, PMID 15818423, PMID 15888773, PMID 16266222, PMID 16937471, PMID 16948806, PMID 16961802, PMID 17230616, PMID 17305763, PMID 17442905, PMID 17767471, PMID 18159172, PMID 18407271, PMID 18507843, PMID 18571296, PMID 18650630, PMID 19198022, PMID 19554657, PMID 19581810, PMID 19925497, PMID 20148732, PMID 20230209, PMID 20458079, PMID 20571304, PMID 20578215, PMID 21073392, PMID 21074910, PMID 21193359, PMID 21266057, PMID 21347742, PMID 21633832, PMID 21775497, PMID 21820770, PMID 22142434, PMID 22241828, PMID 22698649, PMID 23033982, PMID 23733379, PMID 24178185, PMID 25574111
P30CA014599 (1), R01CA091912 (1)